MEDIA & PRESS UPDATES
MEDICINAL CANNABIS USERS IN THE UK COULD BE UNFAIRLY CRIMINALISED AS STUDY FINDS FAILURES IN ROADSIDE DRUG TESTING
February 2, 2022
This Leafie article discusses a recent journal article in JAMA Pyschiatry highlighting how current testing procedures are potentially putting over a million UK drivers at risk. Bloonics was highlighted as a key solution. Our CTO, Lex was quoted in the article.
“We cannot, in good conscience as a society, allow outdated cannabis testing to impose such dangerous and unfair consequences onto medical patients.”
UK POLICE DRUG TESTS DON’T WORK AND CRIMINALISE CANNABIS PATIENTS
February 2, 2002
This cannabiswealth piece further discusses the findings of the JAMA paper and mentions how our system, designed to uniquely find only the active forms of THC is a key solution.
Our CTO, Lex was quoted
“This latest clinical trial only reinforces the desperate need for new, fairer roadside testing. Our innovative LuciX Technology will more accurately detect levels of THC (and associated cannabinoids) as well as active impairment.
Easily usable outside of a laboratory environment, police forces and workplaces will be able to fairly screen for impairment. We truly believe we have the answer to ending the unfair criminalisation of cannabis patients worldwide.”
IT'S TIME TO IMPROVE DRUG TESTING
January 25, 2022
Bloonics was featured in this Volteface piece highlighting the need for impairment focused testing and not generalized toxicology. Our CEO, Dan, details the key features and advantages of the LuciX platform to address this clear and growing need.
“We recognise the harmful consequences of current drug testing systems. At Bloonics we are working on solutions that reduce harm by ensuring cannabis users are not stigmatized or criminalized due to unfair testing systems.”